(19)
(11) EP 1 210 368 A2

(12)

(88) Date of publication A3:
25.10.2001

(43) Date of publication:
05.06.2002 Bulletin 2002/23

(21) Application number: 00961634.3

(22) Date of filing: 07.09.2000
(51) International Patent Classification (IPC)7C07K 14/47, C07K 14/705, A61K 38/17, A61P 35/00, A61P 37/02
(86) International application number:
PCT/US0024/560
(87) International publication number:
WO 0118/044 (15.03.2001 Gazette 2001/11)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 08.09.1999 US 152914 P
27.09.1999 US 156257 P
29.12.1999 US 173906 P

(71) Applicant: IMMUNEX CORPORATION
Seattle, WA 98101-2936 (US)

(72) Inventor:
  • SPRIGGS, Melanie, K.
    Seattle, WA 98119 (US)

(74) Representative: Perry, Robert Edward 
GILL JENNINGS & EVERYBroadgate House7 Eldon Street
London EC2M 7LH
London EC2M 7LH (GB)

   


(54) USE OF SEMAPHORIN FOR MODULATION OF CELLULAR EFFLUX